Mycofoli Syrup contains Mycophenolate Mofetil 1000 mg per 5 ml, a potent immunosuppressant widely used in organ transplant medicine to prevent graft rejection. The syrup formulation offers dose flexibility and ease of administration, making it especially suitable for pediatric patients, elderly individuals, and patients with swallowing difficulties.
Mycophenolate mofetil works by selectively inhibiting inosine monophosphate dehydrogenase (IMPDH), thereby suppressing T- and B-lymphocyte proliferation and reducing immune-mediated injury to transplanted organs. This targeted mechanism helps maintain long-term graft survival while minimizing immune overactivity.
Clinically, Mycofoli Syrup is used in renal, hepatic, and cardiac transplant regimens, often in combination with calcineurin inhibitors and corticosteroids, where precise dose titration is essential for safety and therapeutic success.
The syrup ensures consistent bioavailability, accurate dosing, and reliable immunosuppressive control, making it suitable for hospitals, transplant centers, specialty clinics, and pharmacies that manage complex post-transplant care requiring liquid immunosuppressant therapy.